Loading…
A Comparison of the Physicochemical and Biological Properties of Mirtazapine and Mianserin
Although the chemical structures of the antidepressants mirtazapine and mianserin are closely related there are considerable differences in their biological properties. To find an explanation of this, various physicochemical properties of mirtazapine and mianserin were measured or calculated. Isoste...
Saved in:
Published in: | Journal of pharmacy and pharmacology 1997-04, Vol.49 (4), p.403-411 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5564-d6621145e02bb9d9eb626062f3e020d7220534cde3de9de10fc1e539a6f2ca363 |
---|---|
cites | cdi_FETCH-LOGICAL-c5564-d6621145e02bb9d9eb626062f3e020d7220534cde3de9de10fc1e539a6f2ca363 |
container_end_page | 411 |
container_issue | 4 |
container_start_page | 403 |
container_title | Journal of pharmacy and pharmacology |
container_volume | 49 |
creator | KELDER, JAN FUNKE, CAREL DE BOER, THUS DELBRESSINE, LEON LEYSEN, DIRK NICKOLSON, VICTOR |
description | Although the chemical structures of the antidepressants mirtazapine and mianserin are closely related there are considerable differences in their biological properties. To find an explanation of this, various physicochemical properties of mirtazapine and mianserin were measured or calculated.
Isosteric replacement of CH in mianserin by N in mirtazapine has profound effects on physicochemical properties. The charge distributions as indicated by NMR and calculated by semi‐empirical quantum mechanics differ, not only for the changed aromatic A‐ring (as expected), but also in other regions of the molecule. The N5 atom in particular, which is conjugated to the changed aromatic ring, is less negatively charged in mirtazapine than in mianserin. Consequently the oxidation potential of mirtazapine is significantly higher than that of mianserin. Another result of this difference in charge distribution is that the (calculated) dipole‐moment vectors of the compounds are oriented roughly perpendicular to each other. The dipole moment of mirtazapine is, moreover, three times larger than that of mianserin; mirtazapine is, therefore, more polar than mianserin and this is reflected in a lower retention index. Finally, the basicity of mirtazapine, expressed as the pKa value, is slightly but significantly lower than that of mianserin.
The observed differences between the physicochemical properties of mirtazapine and mianserin result in different interactions of these two antidepressants with macromolecules, such as receptors, transporters and metabolizing enzymes; this might explain the differences observed in pharmacological activity and metabolic and kinetic behaviour, that is, the reduced affinity for the α1‐adrenoceptor and negligible noradrenaline reuptake of mirtazapine compared with mianserin. |
doi_str_mv | 10.1111/j.2042-7158.1997.tb06814.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79149054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79149054</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5564-d6621145e02bb9d9eb626062f3e020d7220534cde3de9de10fc1e539a6f2ca363</originalsourceid><addsrcrecordid>eNqVkF2v0yAYx4nRHOfRj2DSGONdKy8FhlceF7epOzqjxsQbQulTx2xLhS5ufnrbs2b3cgMP_xfID6FnBGdkWC_3GcU5TSXh84woJbO-wGJO8ux4D80u0n00w5jSlHHJHqJHMe4xxlIIcYWuFGWUs_kM_bhJFr7pTHDRt4mvkn4HyXZ3is56u4PGWVMnpi2TN87X_ufduA2-g9A7iGPg1oXe_DWda-HOeOtMGyG49jF6UJk6wpNpv0bflm-_Ltbp5tPq3eJmk1rORZ6WQlBCcg6YFoUqFRSCCixoxYYbXEpKMWe5LYGVoEoguLIEOFNGVNQaJtg1enHu7YL_fYDY68ZFC3VtWvCHqKUiucI8H4yvzkYbfIwBKt0F15hw0gTrEaze65GeHunpEayewOrjEH46vXIoGigv0YnkoD-fdBMHSFUwrXXxYqMiF5zJwfb6bPvjajj9xwf0--16Ox6HivRc4WIPx0uFCb-0kExy_f3jSi9X8suH9XKjP7N_c3SlAg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79149054</pqid></control><display><type>article</type><title>A Comparison of the Physicochemical and Biological Properties of Mirtazapine and Mianserin</title><source>Oxford Journals Online</source><creator>KELDER, JAN ; FUNKE, CAREL ; DE BOER, THUS ; DELBRESSINE, LEON ; LEYSEN, DIRK ; NICKOLSON, VICTOR</creator><creatorcontrib>KELDER, JAN ; FUNKE, CAREL ; DE BOER, THUS ; DELBRESSINE, LEON ; LEYSEN, DIRK ; NICKOLSON, VICTOR</creatorcontrib><description>Although the chemical structures of the antidepressants mirtazapine and mianserin are closely related there are considerable differences in their biological properties. To find an explanation of this, various physicochemical properties of mirtazapine and mianserin were measured or calculated.
Isosteric replacement of CH in mianserin by N in mirtazapine has profound effects on physicochemical properties. The charge distributions as indicated by NMR and calculated by semi‐empirical quantum mechanics differ, not only for the changed aromatic A‐ring (as expected), but also in other regions of the molecule. The N5 atom in particular, which is conjugated to the changed aromatic ring, is less negatively charged in mirtazapine than in mianserin. Consequently the oxidation potential of mirtazapine is significantly higher than that of mianserin. Another result of this difference in charge distribution is that the (calculated) dipole‐moment vectors of the compounds are oriented roughly perpendicular to each other. The dipole moment of mirtazapine is, moreover, three times larger than that of mianserin; mirtazapine is, therefore, more polar than mianserin and this is reflected in a lower retention index. Finally, the basicity of mirtazapine, expressed as the pKa value, is slightly but significantly lower than that of mianserin.
The observed differences between the physicochemical properties of mirtazapine and mianserin result in different interactions of these two antidepressants with macromolecules, such as receptors, transporters and metabolizing enzymes; this might explain the differences observed in pharmacological activity and metabolic and kinetic behaviour, that is, the reduced affinity for the α1‐adrenoceptor and negligible noradrenaline reuptake of mirtazapine compared with mianserin.</description><identifier>ISSN: 0022-3573</identifier><identifier>EISSN: 2042-7158</identifier><identifier>DOI: 10.1111/j.2042-7158.1997.tb06814.x</identifier><identifier>PMID: 9232538</identifier><identifier>CODEN: JPPMAB</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Antidepressive Agents, Tricyclic - chemistry ; Antidepressive Agents, Tricyclic - pharmacokinetics ; Antidepressive Agents, Tricyclic - pharmacology ; Biological and medical sciences ; Biological Availability ; Chromatography, High Pressure Liquid ; Computer Simulation ; Electrochemistry ; Feces - chemistry ; General pharmacology ; Humans ; Hydrogen-Ion Concentration ; Kinetics ; Magnetic Resonance Spectroscopy ; Male ; Medical sciences ; Mianserin - analogs & derivatives ; Mianserin - chemistry ; Mianserin - metabolism ; Mianserin - pharmacokinetics ; Mianserin - pharmacology ; Mirtazapine ; Models, Chemical ; Norepinephrine - metabolism ; Oxidation-Reduction ; Pharmacology. Drug treatments ; Physicochemical properties. Structure-activity relationships ; Quantum Theory ; Radioligand Assay ; Receptors, Adrenergic, alpha-1 - drug effects ; Receptors, Adrenergic, alpha-1 - metabolism ; Serotonin - metabolism ; Structure-Activity Relationship ; Vas Deferens - metabolism</subject><ispartof>Journal of pharmacy and pharmacology, 1997-04, Vol.49 (4), p.403-411</ispartof><rights>1997 Royal Pharmaceutical Society of Great Britain</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5564-d6621145e02bb9d9eb626062f3e020d7220534cde3de9de10fc1e539a6f2ca363</citedby><cites>FETCH-LOGICAL-c5564-d6621145e02bb9d9eb626062f3e020d7220534cde3de9de10fc1e539a6f2ca363</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2646537$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9232538$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KELDER, JAN</creatorcontrib><creatorcontrib>FUNKE, CAREL</creatorcontrib><creatorcontrib>DE BOER, THUS</creatorcontrib><creatorcontrib>DELBRESSINE, LEON</creatorcontrib><creatorcontrib>LEYSEN, DIRK</creatorcontrib><creatorcontrib>NICKOLSON, VICTOR</creatorcontrib><title>A Comparison of the Physicochemical and Biological Properties of Mirtazapine and Mianserin</title><title>Journal of pharmacy and pharmacology</title><addtitle>J Pharm Pharmacol</addtitle><description>Although the chemical structures of the antidepressants mirtazapine and mianserin are closely related there are considerable differences in their biological properties. To find an explanation of this, various physicochemical properties of mirtazapine and mianserin were measured or calculated.
Isosteric replacement of CH in mianserin by N in mirtazapine has profound effects on physicochemical properties. The charge distributions as indicated by NMR and calculated by semi‐empirical quantum mechanics differ, not only for the changed aromatic A‐ring (as expected), but also in other regions of the molecule. The N5 atom in particular, which is conjugated to the changed aromatic ring, is less negatively charged in mirtazapine than in mianserin. Consequently the oxidation potential of mirtazapine is significantly higher than that of mianserin. Another result of this difference in charge distribution is that the (calculated) dipole‐moment vectors of the compounds are oriented roughly perpendicular to each other. The dipole moment of mirtazapine is, moreover, three times larger than that of mianserin; mirtazapine is, therefore, more polar than mianserin and this is reflected in a lower retention index. Finally, the basicity of mirtazapine, expressed as the pKa value, is slightly but significantly lower than that of mianserin.
The observed differences between the physicochemical properties of mirtazapine and mianserin result in different interactions of these two antidepressants with macromolecules, such as receptors, transporters and metabolizing enzymes; this might explain the differences observed in pharmacological activity and metabolic and kinetic behaviour, that is, the reduced affinity for the α1‐adrenoceptor and negligible noradrenaline reuptake of mirtazapine compared with mianserin.</description><subject>Animals</subject><subject>Antidepressive Agents, Tricyclic - chemistry</subject><subject>Antidepressive Agents, Tricyclic - pharmacokinetics</subject><subject>Antidepressive Agents, Tricyclic - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Biological Availability</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Computer Simulation</subject><subject>Electrochemistry</subject><subject>Feces - chemistry</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Kinetics</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mianserin - analogs & derivatives</subject><subject>Mianserin - chemistry</subject><subject>Mianserin - metabolism</subject><subject>Mianserin - pharmacokinetics</subject><subject>Mianserin - pharmacology</subject><subject>Mirtazapine</subject><subject>Models, Chemical</subject><subject>Norepinephrine - metabolism</subject><subject>Oxidation-Reduction</subject><subject>Pharmacology. Drug treatments</subject><subject>Physicochemical properties. Structure-activity relationships</subject><subject>Quantum Theory</subject><subject>Radioligand Assay</subject><subject>Receptors, Adrenergic, alpha-1 - drug effects</subject><subject>Receptors, Adrenergic, alpha-1 - metabolism</subject><subject>Serotonin - metabolism</subject><subject>Structure-Activity Relationship</subject><subject>Vas Deferens - metabolism</subject><issn>0022-3573</issn><issn>2042-7158</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqVkF2v0yAYx4nRHOfRj2DSGONdKy8FhlceF7epOzqjxsQbQulTx2xLhS5ufnrbs2b3cgMP_xfID6FnBGdkWC_3GcU5TSXh84woJbO-wGJO8ux4D80u0n00w5jSlHHJHqJHMe4xxlIIcYWuFGWUs_kM_bhJFr7pTHDRt4mvkn4HyXZ3is56u4PGWVMnpi2TN87X_ufduA2-g9A7iGPg1oXe_DWda-HOeOtMGyG49jF6UJk6wpNpv0bflm-_Ltbp5tPq3eJmk1rORZ6WQlBCcg6YFoUqFRSCCixoxYYbXEpKMWe5LYGVoEoguLIEOFNGVNQaJtg1enHu7YL_fYDY68ZFC3VtWvCHqKUiucI8H4yvzkYbfIwBKt0F15hw0gTrEaze65GeHunpEayewOrjEH46vXIoGigv0YnkoD-fdBMHSFUwrXXxYqMiF5zJwfb6bPvjajj9xwf0--16Ox6HivRc4WIPx0uFCb-0kExy_f3jSi9X8suH9XKjP7N_c3SlAg</recordid><startdate>199704</startdate><enddate>199704</enddate><creator>KELDER, JAN</creator><creator>FUNKE, CAREL</creator><creator>DE BOER, THUS</creator><creator>DELBRESSINE, LEON</creator><creator>LEYSEN, DIRK</creator><creator>NICKOLSON, VICTOR</creator><general>Blackwell Publishing Ltd</general><general>Pharmaceutical Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199704</creationdate><title>A Comparison of the Physicochemical and Biological Properties of Mirtazapine and Mianserin</title><author>KELDER, JAN ; FUNKE, CAREL ; DE BOER, THUS ; DELBRESSINE, LEON ; LEYSEN, DIRK ; NICKOLSON, VICTOR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5564-d6621145e02bb9d9eb626062f3e020d7220534cde3de9de10fc1e539a6f2ca363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Antidepressive Agents, Tricyclic - chemistry</topic><topic>Antidepressive Agents, Tricyclic - pharmacokinetics</topic><topic>Antidepressive Agents, Tricyclic - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Biological Availability</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Computer Simulation</topic><topic>Electrochemistry</topic><topic>Feces - chemistry</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Kinetics</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mianserin - analogs & derivatives</topic><topic>Mianserin - chemistry</topic><topic>Mianserin - metabolism</topic><topic>Mianserin - pharmacokinetics</topic><topic>Mianserin - pharmacology</topic><topic>Mirtazapine</topic><topic>Models, Chemical</topic><topic>Norepinephrine - metabolism</topic><topic>Oxidation-Reduction</topic><topic>Pharmacology. Drug treatments</topic><topic>Physicochemical properties. Structure-activity relationships</topic><topic>Quantum Theory</topic><topic>Radioligand Assay</topic><topic>Receptors, Adrenergic, alpha-1 - drug effects</topic><topic>Receptors, Adrenergic, alpha-1 - metabolism</topic><topic>Serotonin - metabolism</topic><topic>Structure-Activity Relationship</topic><topic>Vas Deferens - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KELDER, JAN</creatorcontrib><creatorcontrib>FUNKE, CAREL</creatorcontrib><creatorcontrib>DE BOER, THUS</creatorcontrib><creatorcontrib>DELBRESSINE, LEON</creatorcontrib><creatorcontrib>LEYSEN, DIRK</creatorcontrib><creatorcontrib>NICKOLSON, VICTOR</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmacy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KELDER, JAN</au><au>FUNKE, CAREL</au><au>DE BOER, THUS</au><au>DELBRESSINE, LEON</au><au>LEYSEN, DIRK</au><au>NICKOLSON, VICTOR</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Comparison of the Physicochemical and Biological Properties of Mirtazapine and Mianserin</atitle><jtitle>Journal of pharmacy and pharmacology</jtitle><addtitle>J Pharm Pharmacol</addtitle><date>1997-04</date><risdate>1997</risdate><volume>49</volume><issue>4</issue><spage>403</spage><epage>411</epage><pages>403-411</pages><issn>0022-3573</issn><eissn>2042-7158</eissn><coden>JPPMAB</coden><abstract>Although the chemical structures of the antidepressants mirtazapine and mianserin are closely related there are considerable differences in their biological properties. To find an explanation of this, various physicochemical properties of mirtazapine and mianserin were measured or calculated.
Isosteric replacement of CH in mianserin by N in mirtazapine has profound effects on physicochemical properties. The charge distributions as indicated by NMR and calculated by semi‐empirical quantum mechanics differ, not only for the changed aromatic A‐ring (as expected), but also in other regions of the molecule. The N5 atom in particular, which is conjugated to the changed aromatic ring, is less negatively charged in mirtazapine than in mianserin. Consequently the oxidation potential of mirtazapine is significantly higher than that of mianserin. Another result of this difference in charge distribution is that the (calculated) dipole‐moment vectors of the compounds are oriented roughly perpendicular to each other. The dipole moment of mirtazapine is, moreover, three times larger than that of mianserin; mirtazapine is, therefore, more polar than mianserin and this is reflected in a lower retention index. Finally, the basicity of mirtazapine, expressed as the pKa value, is slightly but significantly lower than that of mianserin.
The observed differences between the physicochemical properties of mirtazapine and mianserin result in different interactions of these two antidepressants with macromolecules, such as receptors, transporters and metabolizing enzymes; this might explain the differences observed in pharmacological activity and metabolic and kinetic behaviour, that is, the reduced affinity for the α1‐adrenoceptor and negligible noradrenaline reuptake of mirtazapine compared with mianserin.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>9232538</pmid><doi>10.1111/j.2042-7158.1997.tb06814.x</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3573 |
ispartof | Journal of pharmacy and pharmacology, 1997-04, Vol.49 (4), p.403-411 |
issn | 0022-3573 2042-7158 |
language | eng |
recordid | cdi_proquest_miscellaneous_79149054 |
source | Oxford Journals Online |
subjects | Animals Antidepressive Agents, Tricyclic - chemistry Antidepressive Agents, Tricyclic - pharmacokinetics Antidepressive Agents, Tricyclic - pharmacology Biological and medical sciences Biological Availability Chromatography, High Pressure Liquid Computer Simulation Electrochemistry Feces - chemistry General pharmacology Humans Hydrogen-Ion Concentration Kinetics Magnetic Resonance Spectroscopy Male Medical sciences Mianserin - analogs & derivatives Mianserin - chemistry Mianserin - metabolism Mianserin - pharmacokinetics Mianserin - pharmacology Mirtazapine Models, Chemical Norepinephrine - metabolism Oxidation-Reduction Pharmacology. Drug treatments Physicochemical properties. Structure-activity relationships Quantum Theory Radioligand Assay Receptors, Adrenergic, alpha-1 - drug effects Receptors, Adrenergic, alpha-1 - metabolism Serotonin - metabolism Structure-Activity Relationship Vas Deferens - metabolism |
title | A Comparison of the Physicochemical and Biological Properties of Mirtazapine and Mianserin |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A42%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Comparison%20of%20the%20Physicochemical%20and%20Biological%20Properties%20of%20Mirtazapine%20and%20Mianserin&rft.jtitle=Journal%20of%20pharmacy%20and%20pharmacology&rft.au=KELDER,%20JAN&rft.date=1997-04&rft.volume=49&rft.issue=4&rft.spage=403&rft.epage=411&rft.pages=403-411&rft.issn=0022-3573&rft.eissn=2042-7158&rft.coden=JPPMAB&rft_id=info:doi/10.1111/j.2042-7158.1997.tb06814.x&rft_dat=%3Cproquest_cross%3E79149054%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5564-d6621145e02bb9d9eb626062f3e020d7220534cde3de9de10fc1e539a6f2ca363%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79149054&rft_id=info:pmid/9232538&rfr_iscdi=true |